Page last updated: 2024-12-08

barium selenate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

barium selenate: long-acting parenteral selenium supplement for sheep; RN given refers to [1:1]salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID134655
MeSH IDM0124480

Synonyms (14)

Synonym
xew84xni9u ,
unii-xew84xni9u
selenic acid, barium salt (1:1)
einecs 232-113-8
7787-41-9
barium selenate
barium(2+) selenate
A840348
AKOS015916364
Q4413544
selenic acid,bariumsalt(1:1)
DTXSID90884432
barium(2+);selenate
barium selenate(vi)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Cattle had regular blood sampling to assay Se, from 8 days before dosing to 1155 days afterwards."( Depot injection of barium selenate for long-term prevention of selenium inadequacy in beef cattle.
Babidge, PJ; Judson, GJ, 2010
)
0.69
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (35.71)18.7374
1990's3 (21.43)18.2507
2000's2 (14.29)29.6817
2010's4 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.96 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index22.84 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]